Latest News and Press Releases

April 2026 dividend record date

Portfolio receipts: • Achieved over $50 million of cash receipts, including $33.6 million in royalties and $16.9 million milestones, in full year 2025 • Total receipts increased 9% with royalties up...

XOMA Royalty will conduct a webcast to review 4Q and full year 2025 financial results

EMERYVILLE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the...

XOMA Royalty completes its acquisition of Generation Bio and returns capital to GBIO stockholders.

EMERYVILLE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) announced today its Chief Financial Officer, Thomas Burns, will be stepping down from...

Royalty sharing transaction brings 9 additional assets to XOMA Royalty's portfolio

XOMA Royalty Announces January 2026 Dividend

EMERYVILLE, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA), the biotech royalty aggregator, today announced it has successfully completed its...

XOMA Royalty Completes Acquisition of LAVA Therapeutics. Brings 2 partnered assets into XOMA Royalty's milestone and royalty portfolio.